PRIMARY STUDY
Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer
Key Findings: This study on the effects of other compounds from the Cannabis Sativa plant, such as cannaflavin A, causes human bladder cancer cells to die. Further in vivo studies are warranted to better evaluate this activity and understand the mechanism of action as a possible therapeutic adjunct to treat cancer.
Type of Study: Laboratory Study
Study Result: Positive
Research Location(s): Canada
Year of Pub: 2022
Cannabinoids Studied: Cannabichromene (CBC), Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified), Other Related Compounds
Phytocannabinoid Source: Unspecified
Route of Administration: In vitro
Citation: Tomko AM, et al. Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer. J Cannabis Res. 2022; 4:41. doi: 10.1186/s42238-022-00151-y
Authors: Tomko AM, Whynot EG, Dupré DJ
